学术探索
学术期刊
新闻热点
数据分析
智能评审

Fibrinolysis for acute myocardial infarction - Current status and new horizons for pharmacological reperfusion, part 2

被引：22
作者：
Armstrong, PW
Collen, D
机构：
[1] Univ Alberta, Edmonton, AB T6G 2H7, Canada
[2] Katholieke Univ Leuven, Louvain, Belgium
来源：
CIRCULATION | 2001年 / 103卷 / 24期
关键词：
fibrinolysis; myocardial infarction; drugs;
D O I：
10.1161/01.CIR.103.24.2987
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2987 / 2992
页数：6
相关论文
共 61 条
  • [41] ROSS AM, 1993, NEW ENGL J MED, V329, P1615
  • [42] EFFORTS TO LIMIT THE SIZE OF MYOCARDIAL INFARCTS
    RUDE, RE
    MULLER, JE
    BRAUNWALD, E
    [J]. ANNALS OF INTERNAL MEDICINE, 1981, 95 (06) : 736 - 761
  • [43] 1999 Update: ACC/AHA Guidelines for the Management of Patients with Acute Myocardial Infarction: Executive summary and recommendations - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
    Ryan, TJ
    Antman, EM
    Brooks, NP
    Califf, RM
    Hillis, LD
    Hiratzka, LF
    Rapaport, E
    Riegel, B
    Russell, RO
    Smith, EE
    Weaver, WD
    Gibbons, RJ
    Alpert, JS
    Eagle, KA
    Gardner, TJ
    Garson, A
    Gregoratos, G
    Russell, RO
    Ryan, TJ
    Smith, SC
    [J]. CIRCULATION, 1999, 100 (09) : 1016 - 1030
  • [44] RACIAL-DIFFERENCES IN RESPONSES TO THROMBOLYTIC THERAPY WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR - INCREASED FIBRIN(OGEN)OLYSIS IN BLACKS
    SANE, DC
    STUMP, DC
    TOPOL, EJ
    SIGMON, KN
    CLAIR, WK
    KEREIAKES, DJ
    GEORGE, BS
    STODDARD, MF
    BATES, ER
    STACK, RS
    CALIFF, RM
    [J]. CIRCULATION, 1991, 83 (01) : 170 - 175
  • [45] Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction
    Schömig, A
    Kastrati, A
    Dirschinger, J
    Mehilli, J
    Schricke, U
    Pache, J
    Martinoff, S
    Neumann, FJ
    Schwaiger, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (06) : 385 - 391
  • [46] INDIVIDUAL RISK ASSESSMENT FOR INTRACRANIAL HEMORRHAGE DURING THROMBOLYTIC THERAPY
    SIMOONS, ML
    MAGGIONI, AP
    KNATTERUD, G
    LEIMBERGER, JD
    DEJAEGERE, P
    VANDOMBURG, R
    BOERSMA, E
    FRANZOSI, MG
    CALIFF, R
    SCHRODER, R
    BRAUNWALD, E
    [J]. LANCET, 1993, 342 (8886-7) : 1523 - 1528
  • [47] INTRACRANIAL BLEEDING, FIBRINOLYSIS, AND ANTICOAGULATION - CAUSAL CONNECTIONS AND CLINICAL IMPLICATIONS
    SOBEL, BE
    [J]. CIRCULATION, 1994, 90 (04) : 2147 - 2152
  • [48] Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years
    Thiemann, DR
    Coresh, J
    Schulman, SP
    Gerstenblith, G
    Oetgen, WJ
    Powe, NR
    [J]. CIRCULATION, 2000, 101 (19) : 2239 - 2246
  • [49] AN INTERNATIONAL RANDOMIZED TRIAL COMPARING 4 THROMBOLYTIC STRATEGIES FOR ACUTE MYOCARDIAL-INFARCTION
    TOPOL, E
    CALIFF, R
    VANDEWERF, F
    ARMSTRONG, PW
    AYLWARD, P
    BARBASH, G
    BATES, E
    BETRIU, A
    BOISSEL, JP
    CHESEBRO, J
    COL, J
    DEBONO, D
    GORE, J
    GUERCI, A
    HAMPTON, J
    HIRSH, J
    HOLMES, D
    HORGAN, J
    KLEIMAN, N
    MARDER, V
    MORRIS, D
    OHMAN, M
    PFISTERER, M
    ROSS, A
    RUTSCH, W
    SADOWSKI, Z
    SIMOONS, M
    VAHANIAN, A
    WEAVER, WD
    WHITE, H
    WILCOX, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (10) : 673 - 682
  • [50] Topol EJ, 2000, CIRCULATION, V101, P2788
1234567